[HTML][HTML] Intranasal COVID-19 vaccine induces respiratory memory T cells and protects K18-hACE mice against SARS-CoV-2 infection
BK Diallo, C Ní Chasaide, TY Wong, P Schmitt, KS Lee… - npj Vaccines, 2023 - nature.com
Current COVID-19 vaccines prevent severe disease, but do not induce mucosal immunity or
prevent infection with SARS-CoV-2, especially with recent variants. Furthermore, serum …
prevent infection with SARS-CoV-2, especially with recent variants. Furthermore, serum …
[HTML][HTML] Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge
SARS-CoV-2 is a viral respiratory pathogen responsible for the current global pandemic
and the disease that causes COVID-19. All current WHO approved COVID-19 vaccines are …
and the disease that causes COVID-19. All current WHO approved COVID-19 vaccines are …
[HTML][HTML] SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 mice
KS Lee, TY Wong, BP Russ, AM Horspool, OA Miller… - Plos one, 2022 - journals.plos.org
The COVID-19 pandemic has been fueled by SARS-CoV-2 novel variants of concern (VOC)
that have increased transmissibility, receptor binding affinity, and other properties that …
that have increased transmissibility, receptor binding affinity, and other properties that …
[HTML][HTML] Intranasal peptide-based FpvA-KLH conjugate vaccine protects mice from Pseudomonas aeruginosa acute murine pneumonia
…, WT Witt, AC Malkowski, JR Bevere, TY Wong… - Frontiers in …, 2019 - frontiersin.org
Pseudomonas aeruginosa is an opportunistic pathogen causing acute and chronic respiratory
infections associated with morbidity and mortality, especially in patients with cystic fibrosis…
infections associated with morbidity and mortality, especially in patients with cystic fibrosis…
[HTML][HTML] Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis
DT Boehm, MA Wolf, JM Hall, TY Wong, E Sen-Kilic… - npj Vaccines, 2019 - nature.com
Current acellular pertussis vaccines fall short of optimal protection against the human
respiratory pathogen Bordetella pertussis resulting in increased incidence of a previously …
respiratory pathogen Bordetella pertussis resulting in increased incidence of a previously …
Longitudinal temperature measurement can determine humane endpoints in BALB/c mouse models of ESKAPEE infection
RS Dudis, TY Wong, MG Escatte, YA Alamneh… - Virulence, 2023 - Taylor & Francis
Antimicrobial resistance (AMR) is a worldwide problem, which is driving more preclinical
research to find new treatments and countermeasures for drug-resistant bacteria. However, …
research to find new treatments and countermeasures for drug-resistant bacteria. However, …
Intranasal immunization with acellular pertussis vaccines results in long-term immunity to Bordetella pertussis in mice
Bordetella pertussis colonizes the respiratory mucosa of humans, inducing an immune
response seeded in the respiratory tract. An individual, once convalescent, exhibits long-term …
response seeded in the respiratory tract. An individual, once convalescent, exhibits long-term …
[HTML][HTML] CpG 1018® adjuvant enhances Tdap immune responses against Bordetella pertussis in mice
…, JM Hall, E Sen-Kilic, JM Blake, JE Petty, TY Wong… - Vaccine, 2022 - Elsevier
Bordetella pertussis is the causative agent of whooping cough (pertussis), a severe respiratory
disease that can be fatal, particularly in infants. Despite high vaccine coverage, pertussis …
disease that can be fatal, particularly in infants. Despite high vaccine coverage, pertussis …
Evaluation of adenylate cyclase toxoid antigen in acellular pertussis vaccines by using a Bordetella pertussis challenge model in mice
DT Boehm, JM Hall, TY Wong, AM DiVenere… - Infection and …, 2018 - Am Soc Microbiol
Bordetella pertussis is the primary causative agent of pertussis (whooping cough), which is
a respiratory infection that leads to a violent cough and can be fatal in infants. There is a …
a respiratory infection that leads to a violent cough and can be fatal in infants. There is a …
Evaluating antibody mediated protection against Alpha, Beta, and Delta SARS-CoV-2 variants of concern in K18-hACE2 transgenic mice
TY Wong, AM Horspool, BP Russ, C Ye… - Journal of …, 2022 - Am Soc Microbiol
SARS-CoV-2 variants of concern (VoC) are impacting responses to the COVID-19 pandemic.
Here, we utilized passive immunization using human convalescent plasma (HCP) obtained …
Here, we utilized passive immunization using human convalescent plasma (HCP) obtained …